Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -14320.68x is 544% below its 2-year average of -2223.63x, near the low end of its 2-year range (-14320.68x–-3.90x).
As of the fiscal period ended Thursday, June 30, 2022. 302.88% below its 12-month average of -3554.60x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2022 (2022-06-30): -14320.68x.
INTEREST COVERAGE RATIO
-14320.68x
INTEREST COVERAGE RATIO AVG TTM
-3554.60x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-302.88%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.12x
median of 422 covered companies
CURRENT VS SECTOR MEDIAN
-279874.17%
vs the sector median at left
Immix Biopharma, Inc.
Market Cap
$540.21M
Interest Coverage Ratio
-14320.68x
TTM Avg
-3554.60x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$539.46M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$535.97M
Interest Coverage Ratio
-2.35x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$533.39M
Interest Coverage Ratio
-69.85x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$551.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556.18M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$521.52M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$523.14M
Interest Coverage Ratio
-57.76x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$560.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | $540.21M | -14320.68x | -3554.60x | N/A | N/A |
| Delcath Systems, Inc. (DCTH)vs › | $539.46M | N/A | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $535.97M | -2.35x | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $533.39M | -69.85x | N/A | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $551.43M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $556.18M | N/A | N/A | N/A | N/A |
| Monopar Therapeutics Inc. (MNPR)vs › | $521.52M | N/A | N/A | N/A | N/A |
| Altimmune, Inc. (ALT)vs › | $523.14M | -57.76x | N/A | N/A | N/A |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $561.45M | N/A | N/A | N/A | N/A |
Interest Coverage
-14320.7x
Debt/Equity
0.00
Current Ratio
25.13
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2022-06-30 | -14320.68x |
| 2022-03-31 | -3427.93x |
| 2021-12-31 | -13.44x |
| 2021-09-30 | -6.45x |
| 2021-06-30 | -4.51x |
| 2021-03-31 | -5.90x |
| 2020-12-31 | -6.22x |
| 2020-09-30 | -3.90x |
